XML 30 R16.htm IDEA: XBRL DOCUMENT v3.8.0.1
Stock Options and Stock Grants
12 Months Ended
Dec. 31, 2017
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Stock Options and Stock Grants
(10)Stock Options and Stock Grants

 

We have entered into stock option agreements with certain officers, employees and directors. The stock options generally expire ten years from the date of grant.

 

Employee Stock Options

 

We follow ASC Topic 718, Share-Based Payments, in which compensation expense is recognized only for share-based payments expected to vest. We recognized compensation expense related to stock options of $183 and $207 for the years ended December 31, 2017 and 2016, respectively. 

 

As of December 31, 2017, there was approximately $241 of total unrecognized compensation cost related to non-vested share-based compensation arrangements granted under our stock option plans. That cost is expected to be recognized over a remaining weighted-average period of 1.9 years.

 

The following table illustrates the various assumptions used to calculate the Black-Scholes option pricing model for options granted for all years presented:

 

   Years Ended December 31,
   2017  2016
         
Weighted-average risk-free interest rates:   2.1%   1.5%
           
Dividend yield:   0.00%   0.00%
           
Weighted-average expected life of the option:  7 years  7 years
           
Weighted-average expected stock price volatility:   94%   95%
           
Weighted-average fair value of the options granted:  $0.55   $0.36 

 

We use the Black−Scholes option pricing model to determine the fair value of stock-based compensation. The Black−Scholes model requires us to make several assumptions, including the estimated length of time employees will retain their vested stock options before exercising them (“expected term”), the estimated volatility of our common stock price over the expected term and estimated forfeitures. Expected price volatility of the fiscal 2017 and 2016 grants is based on the daily market rate changes of our stock going back to January 1, 2011. The shares granted in fiscal 2017 and 2016 had a vesting period of three years and a contractual life of 10 years. Forfeitures were estimated at 4% for the years ended December 31, 2017 and 2016, based on our historical experience. The Black−Scholes model also requires a risk-free interest rate, which is based on the U.S. Treasury yield curve in effect at the time of the grant, and the dividend yield on our common stock, which is assumed to be zero since we do not pay dividends and have no current plans to do so in the future. Changes in these assumptions can materially affect the estimate of fair value of stock-based compensation and consequently, the related expense recognized on the statement of operations. We recognize stock-based compensation expense on a straight-line basis.

 

The following table summarizes the option activity for our employees and directors during the year ended December 31, 2017:

 

           Weighted     
       Weighted   Average     
       Average   Remaining     
       Exercise Price   Contractual   Aggregate 
   (rounded)   per   Term   Intrinsic 
Options  Shares   Share   (years)   Value 
Outstanding on January 1, 2017   2,933,000   $0.81           
                     
Granted   515,000   $0.68           
Exercised   (118,000)  $0.40           
Forfeited or expired   (189,000)  $2.08           
                     
Outstanding on December 31, 2017   3,141,000   $0.73    5.8   $183 
Exercisable on December 31, 2017   2,296,000   $0.79    4.8   $147 
                     
Shares available for grant   796,000                

 

The aggregate intrinsic value in the table above is based on our closing stock price of $0.52 on the last business day for the year ended December 31, 2017.

 

During the years ended December 31, 2017 and 2016, the total intrinsic value of our stock options exercised was $26 and $19, respectively. Cash received for option exercises was $47 and $18 during the years ended December 31, 2017 and 2016, respectively. We had approximately 118,000 options exercised during the year ended December 31, 2017, compared to 44,000 in 2016. Based on our election of the “with and without” approach, no realized tax benefits from stock options were recognized for the years ended December 31, 2017 and 2016.